Latest Innovation News

S&P Dow Jones Indices has announced its September 2025 quarterly rebalance, reshuffling key constituents across multiple S&P/ASX indices effective September 22. The changes highlight shifting market dynamics with notable additions and removals in sectors ranging from technology to resources.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Lake Resources N.L. has scheduled an Extraordinary General Meeting on 7 October 2025 to seek shareholder approval for the second tranche of its $12 million placement and the issuance of new options to investors and directors.

4DS Memory Limited has had its trading suspension lifted following an important announcement about its collaboration with development partners to chart the future of its technology beyond 2025.

4DS Memory Limited has paused its development activities and ended collaborations with major partners following challenges in advancing its Interface Switching ReRAM technology at the 20nm node. The company has launched a strategic review to explore new pathways aligned with evolving AI and data-centric markets.

Carnegie Clean Energy has secured a pivotal role in a €4 million European Commission-funded project aimed at advancing wave energy technology and reducing costs. The initiative leverages Carnegie’s CETO platform to pioneer innovations that could reshape the future of ocean energy farms.

PYC Therapeutics has completed dosing in its Phase 1 study of PYC-001 for Autosomal Dominant Optic Atrophy, showing strong safety and early signs of improved vision. The company plans to launch a global Phase 1/2 trial later this year.

Orica Limited reports robust earnings growth across all segments for FY2025, underpinned by successful gas supply deals, digital expansion, and progress in hydrogen funding despite ongoing litigation costs.

ALCORE, ABx Group’s subsidiary, has secured government approval for overseas R&D activities and is pursuing a $5 million grant to accelerate its clean fluorine chemical technology commercialisation.

Cobalt Blue Holdings reports key technical milestones at its Broken Hill Technology Centre, progressing toward a final investment decision for its Kwinana Cobalt Refinery by late 2025 amid a recovering cobalt market.

BPH Global has secured a 12-month Master Services Agreement with Singapore’s Marchwood Laboratory Services to enhance its research on extracting rare earth elements from seaweed, focusing on four critical metals vital to clean energy and technology.

ClearVue Technologies has unveiled its Gen3 Solar Vision Glass, achieving a 66% increase in energy output and a 50% reduction in production time and costs, validated by independent testing. This breakthrough positions the company for accelerated commercial adoption in solar-integrated building materials.